Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee

NCT01221441 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

BIOLOGICAL: TissueGene-C
DRUG: Normal Saline

Sponsor

Kolon TissueGene, Inc.